These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 2681605
1. The current status of angiotensin converting enzyme inhibitors in the management of patients with chronic heart failure. Packer M, Kukin ML, Neuberg GW, Pinsky DJ, Penn J, Abittan MH. J Hypertens Suppl; 1989 Sep; 7(5):S33-6. PubMed ID: 2681605 [Abstract] [Full Text] [Related]
2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [Abstract] [Full Text] [Related]
3. [Side effects of vasodilator therapy in heart failure: risk of hypotension with ACE inhibitors]. Kromer EP, Elsner D, Riegger GA. Z Kardiol; 1991 Oct; 80 Suppl 2():11-5. PubMed ID: 2024538 [Abstract] [Full Text] [Related]
4. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure. Anthopoulos L, Apostolou T, Bonoris P, Foussas S, Lefkos N, Zombolos S. Curr Med Res Opin; 2001 Oct; 17(4):290-7. PubMed ID: 11922403 [Abstract] [Full Text] [Related]
5. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction. Thanikachalam S, Manchanda SC. Indian Heart J; 2003 Oct; 55(2):167-71. PubMed ID: 12921333 [Abstract] [Full Text] [Related]
6. [The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure]. Marenzi G, Lauri G, Assanelli E, Grazi M, Guazzi M, Berna G, Salvioni A, Agostoni P. Cardiologia; 1997 Dec; 42(12):1277-83. PubMed ID: 9534323 [Abstract] [Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease. Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV. Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211 [Abstract] [Full Text] [Related]
8. [Digoxin and angiotensin-converting enzyme inhibitors in the treatment of chronic congestive heart failure]. Thery C. Therapie; 1994 Jun; 49(3):211-8. PubMed ID: 7878586 [Abstract] [Full Text] [Related]
9. [Trends in pharmacological treatment of congestive heart failure]. Halawa B. Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602 [Abstract] [Full Text] [Related]
10. [Management of the treatment with converting enzyme inhibitors in chronic heart failure]. Zannad F. Rev Prat; 1992 Dec 15; 42(20):2563-7. PubMed ID: 1299941 [Abstract] [Full Text] [Related]
16. [Therapy of heart failure with ACE inhibitors--"evidence-based medicine" and clinical reality]. Auer J, Berent R, Kirchgatterer A, Weber T, Mayr H, Maurer E, Eber B. Wien Med Wochenschr; 1999 Dec 15; 149(21-22):587-92. PubMed ID: 10666823 [Abstract] [Full Text] [Related]
17. [Indications for ACE inhibitors in chronic heart failure]. Erdmann E. Z Kardiol; 1994 Dec 15; 83 Suppl 4():75-9. PubMed ID: 7856285 [Abstract] [Full Text] [Related]